Depressive illness

Lancet

Volumn 354, Issue 9187, 1999, Pages 1369-1375

  Doris, Alan ^a   Ebmeier, Klaus ^a   Shajahan, Polash ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROCORTISONE; MONOAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; GENETICS; HUMAN; HYPERCORTISOLISM; IMAGING; MOOD; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW;

EID: 0033576169     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03121-9     Document Type: Review

References (85)

1. Boyd J.H., Weissman M.M. Epidemiology. Paykel E.S. Handbook of affective disorders. 1982;112-114.
2. Keller M.B., Shapiro R.W. "Double depression": superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry. 239:1982;438-442.
3. Remick R.A., Sadovnick A.D., Lam R.W., Zis A.P., Yee I.M. Major depression, minor depression, and double depression: are they distinct clinical entities? Am J Med Gen. 67:1996;347-353.
4. Murray C.J.L., Lopez A.D.E. Global burden of disease. 1996;Harvard University Press, Boston.
5. Fombonne E. Increased rates of depression: update of epidemiological findings and analytical problems. Acta Psychiat Scand. 90:1994;145-156.
6. The changing rate of major depression: cross-national comparisons. JAMA. 268:1992;3098-3105.
7. Klerman G.L., Weissman M.M. Increasing rates of depression. JAMA. 61:1989;2229-2235.
8. Bebbington P.E., Jurry J., Tennant C., Wing J.K. The epidemiology of mental disorders in Camberwell. Psychol Med. 11:1981;561-579.
9. Wittchen H.U., Essau C.A., von Zerssen D., Krieg J.C., Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Clin Neurosci. 241:1992;247-258.
10. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 29:1993;85-96.
11. Wiessman M.M., Bland R., Joyce P.R., Newman S., Wells J.E., Wittchen H.U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord. 29:1993;77-84.
12. Shajahan P.M., Cavanagh J.T.O. Admission for depression among men in Scotland, 1980-1995: retrospective study. BMJ. 316:1998;1496-1497.
13. Walsh D. Admission for depression have not increased among men in Republic of Ireland. Br J Psychiatry. 317:1998;1158.
14. Pounder D.J. Changing patterns of male suicide in Scotland. Forensic Sci Int. 51:1991;79-87.
15. Kendler K.S., Kessler R.C., Neale M.C., Heath A.E., Eaves L.J. The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry. 150:1993;1139-1148.
16. Kendler K.S., Karowski L. Stressful life events and liability to major depression: genetic control of exposure to the environment. Psychol Med. 27:1997;539-547.
17. Galbaud du Fort G., Kovess V., Boivin J.F. Spouse similarity for psychological distress and well-being: a population study. Psychol Med. 24:1994;431-447.
18. Merikangas K.R., Spiker D.G. Assortive mating among in-patients with primary affective disorder. Psychol Med. 12:1982;753-764.
19. Spence M.A., Bishop D.T., Boehnke M.et al. Methodological issues in linkage analyses for psychiatric disorders: secular trends, assortative mating, bilineal pedigrees. Report of the MacArthur Foundation Network, I: task force on methodological issues. Hum Hered. 43:1993;166-172.
20. Furlong R.A., Ho L., Walsh C.et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Gen. 81:1998;58-63.
21. Battersby S., Ogilvie A.D., Smith C.A.D.et al. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet. 6:1996;177-181.
22. Heils A., Teufel A., Petri S.et al. Allelic variation of human serotonin transport gene expression. J Neurochem. 66:1996;2621-2624.
23. Delgado P.L., Charney D.S., Price L.H., Aghaganian G.K., Landis L., Heniger G.R. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 47:1990;411-418.
24. Benkelfat C., Ellenbogen M.A., Dean P., Palmour R.M., Young S.N. Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major depressive disorders. Arch Gen Psychiatry. 51:1994;687-697.
25. Cowen P.J. The serotonin hypothesis: necessary but not sufficient. Feighner J.P., Boyer W.F. Selective serotonin re-uptake inhibitors: advances in basic research and clinical practice, 2nd edn. 1996;63-86 John Wiley, Chichester.
26. Staley J.K., Mailson R.T., Innis R.B. Imaging of the serotonin system: interactions of neuroanatomical and functional abnormalities in depression. Biol Psychiatry. 44:1998;534-549.
27. 99mTc-Exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disord. 29:1993;243-253.
28. Shah P.J., Ogilvie A., Goodwin G.M., Ebmeier K.P. Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med. 27:1997;1247-1256.
29. Ebert D. Sleep deprivation and dopamine - the psychostimulant theory of antidepressant sleep deprivation. Ebert D., Ebmeier K.P. New models for depression. 1998;153-169 S Karger, Basle.
30. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry. 147:1990;14-21.
31. Rubin R.T., Phillips J.J., Sadow T.F., McCracken J.T. Adrenal gland volume in major depression - increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry. 52:1995;213-218.
32. Michelson D., Stratakis C., Hill L.et al. Bone mineral density in women with depression. N Engl J Med. 335:1996;1176-1181.
33. Halbreich U., Rojansky N., Palter S.et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med. 57:1995;485-491.
34. Sapolsky R.M., Krey L.C., McEwen B. The neuroendocrinology of stress and ageing: the glucocorticoid cascade hypothesis. Endocr Rev. 7:1985;284-301.
35. Shah P.J., Ebmeier K.P., Glabus M.F., Goodwin G.M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: a controlled MRI study. Br J Psychiatry. 172:1998;527-532.
36. Bench C.J., Frackowiak R.S.J., Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 25:1995;247-251.
37. Kenner T.A., Andreason P.J., George M.S.et al. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 25:1995;247-251.
38. George M.S., Nahas Z., Speer A.M.et al. Transcranial magnetic stimulation (TMS) - a new method for investigating the neuroanatomy of depression. Ebert D., Ebmeier K.P. Biological psychiatry: new models for depression. 1998;94-122 Karger, Basel.
39. Ebmeier K.P., Cavanagh J.T.O., Moffoot A.P.R., Glabus M.F., Ocarroll R.E., Goodwin G.M. Cerebral perfusion correlates of depressed mood. Br J Psychiatry. 170:1997;77-81.
40. Coffey C.E., Wilkinson W.E., Weiner R.D.et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 50:1993;7-16.
41. Axelson D.A., Doraiswamy P.M., McDonald W.M.et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 47:1993;163-173.
42. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:1996;3908-3913.
43. Young M.A., Meaden P.M., Fogg L.F., Cherin E.A., Eastman C.I. Which environmental variables are related to the onset of seasonal affective disorder? J Abnorm Psychol. 106:1997;554-562.
44. Murray G.W., Hay D.A. Seasonal affective disorder in Australia: is photoperiod critical? Aust N Z J Psychiatry. 31:1997;279-284.
45. Lee T.M.C., Chan C.C.H., Paterson J.G., Janzen H.L., Blashko C.A. Spectral properties of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiat Scand. 96:1997;117-121.
46. Kogan A.O., Guildford P.M. Side-effects of short-term 10,000-lux light therapy. Am J Psychiatry. 155:1998;293-294.
47. Praschak-Rieder N., Neumeister A., Hesselmann B., Willeit M., Barnas C., Kasper S. Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J Clin Psychiatry. 58:1997;389-392.
48. Neumeister A., Praschak-Rieder N., Besselmann B., Rao M.L., Gluck J., Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 54:1997;133-138.
49. Ruhrmann S., Kasper S., Hawellek B.et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychol Med. 28:1998;923-933.
50. Freeling P., Rao B.M., Paykel E.S., Sireling L.I., Burton R. Unrecognised depression in general practice. BMJ Clin Res Ed. 290:1985;1880-1883.
51. Paykel E.S., Hart D., Priest R.G. Changes in public attitudes to depression during the Defeat Depression Campaign. Br J Psychiatry. 173:1998;519-522.
52. Joffe R., Sokolov S., Streiner D. Antidepressant treatment of depression: a metaanalysis. Can J Psychiatry. 41:1996;613-616.
53. Goldstein B.J., Goodnick P.J. Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerabilitiy, safety and pharmacoeconomics. J Psychopharmacol. 12:1998;55-87.
54. Perry P.J. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord. 39:1996;1-6.
55. Amsterdam J.D. Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression. J Psychopharmacol. 12:1998;99-111.
56. Clinical trial of the treatment of depressive illness. BM. 1:1965;881-886.
57. Thase M.E., Greenhouse J.B., Frank E.et al. Treatment of major depression with psychotherapy or psychotherapy - pharmacotherapy combinations. Arch Gen Psychiatry. 54:1997;1009-1015.
58. Devanard D.P., Dwork A.T., Hutchinson E.R., Bolwig T.G., Sackeim H.A. Does ECT alter brain structure? Am J Psychiatry. 151:1994;957-970.
59. Pascual-Leone A., Rubio B., Pallardó F., Catalá M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
60. George M.S., Wasserman E.M., Kinbrell T.A.et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 154:1997;1752-1756.
61. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St John's Wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ. 313:1996;253-258.
62. Byrne A., Byrne D.G. The effect of exercise on depression, anxiety, and other mood states: a review. J Psychosomat Res. 37:1993;565-574.
63. Elkin I., Shea M.T., Watkins J.T.et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry. 46:1989;971-982.
64. Prien R.F., Kupfer D.J. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 143:1986;18-23.
65. Keller M. Depression: a long-term illness. Br J Psychiatry. 165:1994;9-15.
66. Piccinelli M., Wilkinson G. Outcome of depression in psychiatric settings. Br J Psychiatry. 164:1994;297-304.
67. Frank E., Kupfer D.J., Perel J.M.et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 47:1990;1093-1099.
68. Montgomery S.A. Antidepressants in long-term treatment. Ann Rev Med. 45:1994;447-457.
69. Goodnick P.J., Goldstein B.J. Selective serotonin reuptake inhibitors in affective disorders - II: efficacy and quality of life. J Psychopharmacol. 12:1998;21-54.
70. Blackburn I.M., Bishop S., Glen A.I.M., Whalley L.J., Christie J.E. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 139:1981;181-189.
71. Evans M.D., Hollon S.D., J D.R.et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 49:1992;802-808.
72. Fava G.A., Rafanelli C., Grandi S., Conti S., Bulluardo P. Prevention of recurrent depression with cognitive behavioural therapy - preliminary findings. Arch Gen Psychiatry. 55:1998;816-820.
73. Prien R.F., Klett C.J., Caffey E.M. Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry. 29:1973;420-425.
74. Rabheru K., Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry. 42:1997;476-484.
75. Keller M.B., Klerman G.L., Lavori P.W. Treatment received by depressed patients. JAMA. 248:1982;1848-1855.
76. McAskill R., Mir S., Taylor D. Pindolol augmentation of antidepressant therapy. Br J Psychiatry. 173:1998;203-208.
77. Wittchen H.U., Knauper B., Kessler R. Lifetime risk of depression. Br J Psychiatry. 165:1994;16-22.
78. Eaton W.W., Kramer M., Anthony J.C., Dryman A., Shapiro S., Locke B.Z. The incidence of specific DIS/DSM-II mental disorders: data frm the NIMH epidemiological catchment area program. Acta Psychiatr Scand. 79:1989;163-178.
79. Johnstone E.C., Deakin J.F., Lawler P.et al. The Northwick Park Electroconvulsive Therapy Trial. Lancet. 2:1980;1317-1320.
80. Buchan H., Johnstone E.C., McPherson K., Palmer R.L., Crow T.J., Brandon S. Who benefits from electro-convulsive therapy? Br J Psychiatry. 160:1992;355-359.
81. Freeman C.P. The ECT Handbook. 1995;Royal College of Psychiatrists, London.
82. Reid P.D., Shajahan P.M., Glabus M.F., Ebmeier K.P. Transcranial magnetic stimulation in depression. Br J Psychiatry. 173:1998;449-452.
83. Ernst E., Rand J.I., Stevison C. Complementary therapies for depression: an overview. Arch Gen Psychiatry. 173:1998;449-452.
84. Zulman D.M., Oren D.A. Seasonal affective disorder. Curr Opin Psychiatr. 12:1999;86.
85. Partonen T., Lonngvist J. Seasonal affective disorder. Lancet. 352:1998;1369-1374.